The Effect of Herpes Zoster Episodes and Vaccines on Health and Cognition
Objectif(s) de la recherche et intérêt pour la santé publique
Finalité de l'étude
Objectifs poursuivis
Domaines médicaux investigués
Bénéfices attendus
Objectives:
In this study, we aim to determine the effect of the herpes zoster episodes and vaccine on the incidence of cardiovascular disease (acute myocardial infarction and stroke), chronic kidney disease, neurodegenerative diseases (dementia and Parkinson's disease), and cognitive functioning.\\
Methods:
We will employ several methodological approaches. In a first step, we will use standard multivariate regression approaches as well as propensity-score matching designs. To account for non-random herpes zoster infections and vaccine uptake, we want to include a large a set of available sociodemographic and clinical characteristics available in CONSTANCES. By this means, we aim to determine the pathway on different health outcomes. Yet, there are further unobserved characteristics that may confound our analysis and respective estimates. In a second step, we will thus leverage quasi-experimental estimation procedures exploiting differences in the timing of infections and vaccines as well as changes in the likelihood to get vaccinated following adjustments in the national vaccination schedule in 2016. By this means, we aim to complement randomized controlled trial studies, while fully capturing real-life and longer-run effects.
Perspectives:
With our study, we aim to inform about important (short- and long-term) health effects and potential side effects on cognitive functioning that come along with herpes zoster infections. In addition, we aim to enhance our understanding of the effectiveness of relevant vaccines. These insights are important for public health decisions on investments into making the herpes zoster vaccine broadly available and interventions to improve Herpes Zoster vaccine coverage. While our results will be most pertinent to the French context, we believe that our analysis can inform policy makers and practitioners in many other similar countries.
Study Subjects or Subsets:
Following pre-existing observational studies, we want to compare patients with herpes zoster episodes and vaccine uptake along several health outcomes with those individuals who remained unaffected. To maximize statistical power and the pool of observable control dimensions, we want to include all patients aged 18 years or older in our analysis.
Données utilisées
Catégories de données utilisées
Source de données utilisées
Autre(s) source(s) de donnée(s) mobilisée(s)
Appariement entre les sources de données mobilisées
Plateforme utilisée pour l'analyse des données
Acteurs finançant et participant à l'étude
Responsable(s) de traitement
Type de responsable de traitement 1
Responsable de traitement 1
Localisation du responsable de traitement 1
Représentant du responsable de traitement 1
Calendrier du projet
Base légale pour accéder aux données
Encadrement réglementaire
Durée de conservation aux fins du projet (en années)
3
Existence d'une prise de décision automatisée
Fondement juridique
Article 6 du RGPD (Licéité du traitement)
Article 9 du RGPD (Exception permettant de traiter des données de santé)
Transfert de données personnelles vers un pays hors UE
Droits des personnes
This project exclusively uses secondary data. The data controller does not and will not engage in direct data collection from subjects. This limitation precludes direct contact with data subjects, which impacts the ability to directly manage rights such as access, rectification, and erasure. These rights are managed through the data processor with the appropriate data subject contact protocols. Please refer to CONSTANCES for details on the information provided to the data subjects: https://www.constances.fr/wp-content/uploads/2024/06/ENG-Constances-Cha….